The Novel Mutations of GATA4 Gene in Chinese Patients with Sporadic Congenital Heart Defects
Jing-dong Ding,Jiayi Tong,Kairu Li,Xiang Fang,Hao Li,Xiaoli Zhang,Yuyu Yao,Genshan Ma
DOI: https://doi.org/10.15761/jic.1000124
2015-01-01
Journal of Integrative Cardiology
Abstract:Background: Congenital heart defects (CHD) are a major cause of substantial morbidity and mortality in infants. Recent reports have identified that mutations in a few genes, including T-BOX5, NKX2.5, EVC and GATA4, are associated with CHD. The prevalence of GATA4 gene mutations in Chinese patients with sporadic CHD is unknown. Here, the authors aimed to examine Chinese patients with sporadic CHD to find out whether there is any mutation in GATA4 accounting for the etiology. Methods: A cohort of 99 unrelated patients with sporadic CHD was included in the study, among which 93 patients had simple heart defects, such as atrial septal defect (ASD), ventricular septal defect (VSD), pulmonary valvar stenosis (PVS) and patent ductus arteriosus (PDA) and 6 patients had a variety of complex heart defects. A total of 90 unrelated ethnically matched healthy individuals were recruited as controls. After amplifying the exon 3 of the GATA4 gene by polymerase chain reaction (PCR), we purified the PCR products and conducted the sequencing reaction, analyzed the mutation of the GATA4 gene. Results: Three inserted mutations (52, 58, 61) with base A in the exon 3 of the GATA4 gene were identified in 3 of 21 patients with PDA, but none were found in controls. Conclusion: Our results suggest that GATA4 gene mutations may be one of etiologic causes of congenital heart defect in Chinese people. However, the mechanism by which this mutation contributes to the development of a congenital heart defect remains to be ascertained. Introduction Congenital heart defects (CHD) is the most prevalent form of developmental abnormality in newborns, with an estimated prevalence of 1%, and is the leading non-infectious cause of infant mortality, with more than 29% of neonates who die of a birth defect having a cardiovascular deformity [1]. Nevertheless, the aetiology of CHD in the majority of cases remains largely unclear. CHD is a diverse group of diseases determined by genetic and environmental factors. Therefore, screening for disease causing or susceptibility genes, identifying new genetic mutations associated with CHD and further studying the functions of CHD susceptibility genes are focused on current genetic research. Heart formation is a complex process regulated by many transcription factors. Although most of CHD cases are sporadic, there are several genes which were found to be associated with CHD, including NKX2.5, TBX5, GATA4, etc. Recent studies have identified mutations in these genes which could cause heart developmental anomalies and lead to heart disease. Mutations of NKX2.5 have been reported that might cause congenital heart diseases [2-4]. Recently, heterozygous mutations in the GATA4 zinc finger transcription factor gene have been identified in patients with CHD, such as ventricular septal defect (VSD) [5,6], atrial septal defect (ASD) [7-9], tetralogy of Fallot (TOF) [10], and so on. The GATA4 gene is one of the genes encoding zinc-finger transcriptional factors which are vital to the cardiac development. The GATA4 protein binds the GATA motif consensus sequence to modulate the transcription of target genes. GATA4 has 442 amino acids with two transactivation domains; two zinc fingers, one at the N-terminus (NZf) and the other at the C-terminus (CZf); and a nuclear localization signal (NLS), for import into the nucleus. The CZf and the adjacent basic domain of GATA4 have dual functions in both DNA binding and nuclear localization. The amino acids 270–324 fragment within the DNA-binding domain at amino acids 216–324 has been identified as the minimal, functional NLS region for actively transporting GATA4 into the nucleus of both HeLa cells and cardiac myocytes [11]. To identify the mutations of GATA4 gene in Chinese patients with sporadic CHD, we analyzed the sequence of the transcription factor GATA4 using DNA extracted from whole peripheral blood of 99 consecutive patients diagnosed with CHD. Methods Study subjects 99 unrelated CHD patients (38 men, 61 women; mean age 21.5 ± 11.8, range 1 to 65 years) obtained from Department of Cardiology, Zhongda hospital and School of Clinical Medicine Southeast University, Nanjing, China and 90 healthy volunteers matched for age and gender (42 men, 48 women; mean age 22.1 ± 12.3, range 12 to Correspondence to: Jing-dong Ding, Department of Cardiology, Zhongda hospital and School of Clinical Medicine, Southeast University, 87 Ding Jia Qiao Road, Nanjing, 210009, China, Tel: 86-25-83272042; Fax: 86-25-83272042; E-mail: dingjiandong@163.com